AskAt received a Notice of Allowance dated January 25, 2024 from the Canadian Intellectual Property Office (CIPO) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Canadian Patent Application No. 3,196,706 (Filing Date: November 11, 2021). In addition to Canada, salt and crystal forms patents have also been granted in Japan, Korea, Australia, and Mexico.
